Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial.
Kentaro MachidaTomotaka KawayamaMasaharu KinoshitaMasakazu IchinoseTohru TsudaShohei TakataHiroshi KotoMakoto YoshidaYoshinori AshiharaMasaru KawashimaHideaki SunaHiromasa InouePublished in: International journal of chronic obstructive pulmonary disease (2019)
JapicCTI-121760 (Japan Pharmaceutical Information Center - Clinical Trials Information [JapicCTI]; http://www.clinicaltrials.jp/user/cteSearch_e.jsp).